Essential Insights and Industry Implications of ANVISA’s New Regulatory Framework Regulatory Directive and Legal Foundations in the 2024 ANVISA Controlled Substance Update The ANVISA Controlled Substance Update 2024 reinforces ANVISA’s commitment to public health protection through vigilant oversight of substances that may lead to misuse. Grounded in Brazilian legislative framework, specifically Law No. 9,782 of […]